NCT05315765

Brief Summary

People who undergo surgery, or develop intestinal obstruction will spend a period of time without normal bowel function. This might extend beyond the normal measures of passage of flatus or tolerance of diet. This study will take a three stage approach to develop a patient reported outcome measure for gastrointestinal recovery. Stage 1: Qualitative interviews with 20-40 patients who have undergone major abdominal surgery, or conservatively managed intestinal obstruction. These interviews will identify key themes and ideas to develop the questionnaire. Stage 2: Face validity testing of questionnaire with 20 patients, using the QQ-10 questionnaire to aid assessment. The questionnaire may be edited after this. Stage 3: 250-500 patients will be asked to complete the questionnaire following surgery or treatment for intestinal obstruction. Basic demographics will also be collated. Item reduction and scale refinement will be undertaken using this dataset. This will provide a PROM of gastrointestinal recovery which is ready for validation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
560

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2021

Completed
21 days until next milestone

Study Start

First participant enrolled

October 28, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 7, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

April 7, 2022

Status Verified

March 1, 2022

Enrollment Period

1.3 years

First QC Date

October 7, 2021

Last Update Submit

March 30, 2022

Conditions

Keywords

PROMsurgery

Outcome Measures

Primary Outcomes (3)

  • Completion of interviews (stage one)

    completions of interview by group 1

    Within one month of treatment

  • Completion of questionnaire (stage three)

    completion of questionnaire by group 3

    Within two weeks of treatment

  • Completion of face validity assessment (stage two)

    Assessment of face validity using the QQ-10 (Questionnaire quality-10 item) questionnaire by group 2

    Within one month of treatment

Study Arms (3)

Phase 1

Qualitative interviews with patients to generate thematic framework and questionnaire

Phase 2

Face validity assessment of questionnaire

Phase 3

Completion of questionnaire to refine scale and item list

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing major abdominal surgery for gastrointestinal, urological, or gynaecological indications OR patients being treated for intestinal obstruction regardelss of aetiology.

You may qualify if:

  • Adult patients (aged 18+) admitted to hospital for one of the following reasons will be eligible to participate:
  • Undergoing major elective gastrointestinal surgery (e.g. colorectal resection, gastric resection, liver or pancreatic resection)
  • Emergency laparotomy for non-trauma indication
  • Patients undergoing intra-abdominal surgery for non-gastrointestinal indications e.g.cystoprostatectomy, prostatectomy, nephrectomy, hysterectomy, or oophorectomy.
  • With a diagnosis of intestinal obstruction (small or large bowel).
  • Participants are permitted to participate in another study or trial in addition to PRO-DIGI

You may not qualify if:

  • Non conversationaI standard of English
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, South Yorkshire, S5 7AU, United Kingdom

RECRUITING

MeSH Terms

Conditions

IleusIntestinal Failure

Condition Hierarchy (Ancestors)

Intestinal ObstructionIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Matthew Lee, PhD

    University of Sheffied and Sheffield Teaching Hospitals

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Debby Hawkins, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2021

First Posted

April 7, 2022

Study Start

October 28, 2021

Primary Completion

January 30, 2023

Study Completion

March 30, 2023

Last Updated

April 7, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Anonymised transcriptions of phase one interviews will be made available on our institution open access data repository. Other data relates to refinement of the PROM and is not relevant outside of this study.

Locations